GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fagron SA (XBRU:FAGR) » Definitions » Total Equity

Fagron (XBRU:FAGR) Total Equity : €505.4 Mil (As of Dec. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Fagron Total Equity?

Fagron's total equity for the quarter that ended in Dec. 2024 was €505.4 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Fagron Total Equity Historical Data

The historical data trend for Fagron's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fagron Total Equity Chart

Fagron Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 257.82 325.47 410.52 467.63 505.36

Fagron Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 410.52 440.53 467.63 477.11 505.36

Fagron Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Fagron's Total Equity for the fiscal year that ended in Dec. 2024 is calculated as

Total Equity=Total Assets(Q: Dec. 2024 )-Total Liabilities(Q: Dec. 2024 )
=1083.518-578.16
=505.4

Fagron's Total Equity for the quarter that ended in Dec. 2024 is calculated as

Total Equity=Total Assets(Q: Dec. 2024 )-Total Liabilities(Q: Dec. 2024 )
=1083.518-578.16
=505.4

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fagron Total Equity Related Terms

Thank you for viewing the detailed overview of Fagron's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Fagron Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fagron SA (XBRU:FAGR) » Definitions » Total Equity
Comparable Companies
ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ HKSE:03692 NSE:DIVISLAB XTAE:TEVA ITCI SZSE:000538 UTHR BOM:500087 TSE:4507 SHSE:688506 NSE:TORNTPHARM BOM:543904 NBIX BOM:500124
Traded in Other Exchanges
0HNZ:UK 4A5:Germany
Address
Fascinatio Boulevard 350, Rotterdam, ZH, NLD, 3065 WB
Website
https://www.fagron.com
Fagron SA is a pharmaceutical compounding company operating in Belgium. It acts as a supplier of pharmaceutical care to hospitals, pharmacies, clinics, and patients across the world. The company also produces pharmaceutical raw materials, equipment, and supplies that are needed to prepare medication in the pharmacy. Its segments are namely Fagron Europe, Middle East and Africa (EMEA), Fagron North America, and Fagron Latin America. The majority of its revenue comes from Fagron North America.

Fagron Headlines

No Headlines